We are live on ! Find out more
TIL icon

Instil Bio

30 hedge funds and large institutions have $43.5M invested in Instil Bio in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.31% less ownership

Funds ownership: 65.35%65.04% (-0.31%)

3% less funds holding

Funds holding: 3130 (-1)

5% less capital invested

Capital invested by funds: $45.9M → $43.5M (-$2.37M)

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.43%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
3
Increased
7
Reduced
8
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
LC
26
Lindbrook Capital
California
$700
UBS Group
27
UBS Group
Switzerland
$329 -$2.45K -227 -88%
Bank of America
28
Bank of America
North Carolina
$329 +$335 +31 +3,100%
FFA
29
Frazier Financial Advisors
Ohio
$155
Qube Research & Technologies (QRT)
30
Qube Research & Technologies (QRT)
United Kingdom
$10
Squarepoint
31
Squarepoint
New York
-$188K -17,367 Closed
Citadel Advisors
32
Citadel Advisors
Florida
-$167K -15,438 Closed
Wells Fargo
33
Wells Fargo
California
-$335 -31 Closed
Osaic Holdings
34
Osaic Holdings
Arizona
-$140 -13 Closed

TIL Hedge Fund Activity: Q2 2024 in Review

30 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q2 2024, worth a combined $43.5M — down 5.2% from $45.9M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of TIL and 3 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 7 added.

The largest buyer was BML Capital Management, adding an estimated $458K. The largest seller was Two Sigma Investments, cutting an estimated $223K.

  • 30 institutional investors held Instil Bio (TIL) as of Q2 2024, down from 31 in Q1 2024.
  • Funds reported $43.5M of Instil Bio stock for Q2 2024, down 5.2% quarter-over-quarter.
  • 3 funds opened new Instil Bio positions in Q2 2024 and 4 closed out, a net change of -1 holder.
  • The largest Instil Bio buyer in Q2 2024 was BML Capital Management, an estimated $458K added.
  • The largest Instil Bio seller in Q2 2024 was Two Sigma Investments, an estimated $223K sold.

Based on aggregated 13F filings for Q2 2024.